FIELD: medicine, laboratory diagnostics.
SUBSTANCE: the present innovation deals with predicting gestosis development in the 3d trimester of pregnancy. At the terms of 6-13 wk of gestation one should detect the activity of cathepsin D in peripheral venous blood and at its value being either equal or above 0.021 U/h one should predict gestosis development in the 3d trimester. The innovation provides prediction of gestosis development since the early terms of pregnancy.
EFFECT: higher accuracy of prediction.
3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING LIGHT-DEGREE GESTOSIS SINCE EARLY TERMS OF PREGNANCY | 2004 |
|
RU2265221C2 |
| METHOD FOR PREDICTION OF PREECLAMPSIA IN SECOND TRIMESTER OF PREGNANCY | 2014 |
|
RU2552931C1 |
| METHOD FOR PREDICTING GESTOSIS IN PREGNANT WOMEN WITH THE RISK FOR MISCARRIAGE OF INFECTIOUS GENESIS | 2003 |
|
RU2246255C2 |
| DIAGNOSTIC TECHNIQUE FOR SEVERE GESTOSIS | 2011 |
|
RU2476880C1 |
| METHOD FOR EARLY PREDICTION OF GESTOSIS | 2004 |
|
RU2271541C1 |
| METHOD FOR PREDICTING THE SYNDROME FOR DELAYED FETAL DEVELOPMENT | 2004 |
|
RU2265224C1 |
| METHOD FOR GENETIC MARKER PREDICTION OF RISK OF GESTOSIS | 2010 |
|
RU2431842C1 |
| METHOD FOR PREDICTING PERINATAL HYPOXIA INJURIES OF NEWBORN CENTRAL NERVOUS SYSTEM | 2006 |
|
RU2313095C1 |
| METHOD FOR PREDICTING LATE GESTOSIS | 1995 |
|
RU2107916C1 |
| METHOD FOR EARLY PREDICTION OF FETAL GROWTH RETARDATION | 2019 |
|
RU2718725C1 |
